| Both sides previous revisionPrevious revisionNext revision | Previous revisionBoth sides next revision |
lucia_zhang [2023/05/27 09:40] liam | lucia_zhang [2023/11/07 18:46] (current) liam |
|---|
| |
| **Lucia Zhang** is a Canadian regulatory official based in [[canada:ontario:Ottawa]], [[canada:Ontario]]. She is a Senior Clinical Evaluator at [[Health Canada]]'s [[Biologic and Radiopharmaceutical Drugs Directorate]] (BRDD).((//Lucia Zhang.// LinkedIn. Retrieved May 27, 2023, from http://archive.today/2023.05.27-053527/https://www.linkedin.com/in/lucia-zhang-53143226/)) ((//Lucia Zhang · Health Canada · Clinical Evaluator.// OpenGovCa. Retrieved May 27, 2023, from https://web.archive.org/web/20230527053643/https://opengovca.com/employee/lucia-zhang)) | **Lucia Zhang** is a Canadian regulatory official based in [[canada:ontario:Ottawa]], [[canada:Ontario]]. She is a Senior Clinical Evaluator at [[Health Canada]]'s [[Biologic and Radiopharmaceutical Drugs Directorate]] (BRDD).((//Lucia Zhang.// LinkedIn. Retrieved May 27, 2023, from http://archive.today/2023.05.27-053527/https://www.linkedin.com/in/lucia-zhang-53143226/)) ((//Lucia Zhang · Health Canada · Clinical Evaluator.// OpenGovCa. Retrieved May 27, 2023, from https://web.archive.org/web/20230527053643/https://opengovca.com/employee/lucia-zhang)) |
| | |
| | She is a member of the [[American Society for Pharmacology and Experimental Therapeutics]] (ASPET) and the [[American Society for Bone and Mineral Research]] (ASBMR).((//Organizations | Lucia Zhang.// LinkedIn. Retrieved May 27, 2023, from https://www.linkedin.com/in/lucia-zhang-53143226/details/organizations/)) |
| |
| ===== History ===== | ===== History ===== |
| ==== Education ==== | ==== Education ==== |
| |
| Zhang attended the [[University of Toronto]] from September 2009 to June 2013 for her Bachelor of Science in Pharmacology and Toxicology, and September 2013 to June 2018 for her Doctor of Philosophy in Pharmacology.((//Lucia Zhang.// LinkedIn. Retrieved May 27, 2023, from http://archive.today/2023.05.27-053527/https://www.linkedin.com/in/lucia-zhang-53143226/)) She worked as as Summer Intern at [[National Research Council Canada]] (NRC) from May to August 2010. She volunteered at [[Toronto Western Hospital]] from September 2012 to June 2013. | Zhang attended the [[University of Toronto]] from September 2009 to June 2013 for her Bachelor of Science in Pharmacology and Toxicology, and September 2013 to June 2018 for her Doctor of Philosophy in Pharmacology.((//Lucia Zhang.// LinkedIn. Retrieved May 27, 2023, from http://archive.today/2023.05.27-053527/https://www.linkedin.com/in/lucia-zhang-53143226/)) She worked as as Summer Intern at [[National Research Council Canada]] (NRC) from May to August 2010. She served in several roles at the [[Pharmacology and Toxicology Students' Association]] and the [[Pharmacology Graduate Students' Association]].((//VIP 2018 Abstract Booklet.// University of Toronto. Retrieved May 27, 2023, from https://web.archive.org/web/20230528054627/https://pharmtox.utoronto.ca/sites/default/files/VIP%202018%20Booklet%20Final.pdf)) |
| | |
| | Zhang conducted research in the [[Grynpas Lab]] at the [[Lunenfeld-Tanenbaum Research Institute]].((//Lucia Zhang | Dr. Marc Grynpas.// Lunenfeld-Tanenbaum Research Institute. Retrieved May 28, 2023, from http://archive.today/2023.05.28-053645/https://research.lunenfeld.ca/grynpas/Default.asp?page=lucia-zhang)) She volunteered at [[Toronto Western Hospital]] from September 2012 to June 2013. |
| |
| ==== Career ==== | ==== Career ==== |
| === COVID-19 ==== | === COVID-19 ==== |
| |
| Zhang participated in the 14th [[Workshop on Recent Issues in Bioanalysis]] from June 15-29, 2020. | Zhang participated in the 14th [[Workshop on Recent Issues in Bioanalysis]] from June 15-29, 2020. The conference was partnered with the [[Future Science Group]] (FSG). |
| |
| On February 2021, the journal //[[journals:Bioanalysis]]// published a paper co-authored by Zhang titled //2020 White Paper on Recent Issues in | On February 2021, the journal //[[journals:Bioanalysis]]// published a paper co-authored by Zhang titled //2020 White Paper on Recent Issues in |
| |
| Zhang was promoted to Senior Clinical Evaluator in March 2021. | Zhang was promoted to Senior Clinical Evaluator in March 2021. |
| | |
| | ===== Activities ===== |
| | |
| | Zhang has participated in research funded by the [[Canadian Institutes of Health Research]] (CIHR).((Zhang, L., Sugamori, K. S., Claridge, C., dela Cruz, A., Grynpas, M. D., & Mitchell, J. (2017). //Overexpression of GαS in Murine Osteoblasts In Vivo Leads to Increased Bone Mass and Decreased Bone Quality.// Journal of Bone and Mineral Research, 32(11), 2171–2181. https://doi.org/10.1002/jbmr.3223)) |
| |
| ===== External links ===== | ===== External links ===== |
| |
| | * [[https://covidtruthinitiative.ca/en/Individuals/Lucia-Zhang|COVID Truth Initiative]] |
| | * [[https://web.archive.org/web/20230528060056/https://www.ema.europa.eu/sites/default/files/ContactsAndExperts_CVs_and_DOIs/zhang_l20_CV_en.pdf|Curriculum Vitae (European Medicines Agency)]] |
| * [[https://www.linkedin.com/in/lucia-zhang-53143226/|LinkedIn]] | * [[https://www.linkedin.com/in/lucia-zhang-53143226/|LinkedIn]] |
| | * [[https://www.researchgate.net/profile/Lucia-Zhang-3|ResearchGate]] |